276 related articles for article (PubMed ID: 11100332)
1. Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test.
Nakama H; Fattah AS; Zhang B; Kamijo N; Uehara Y
Hepatogastroenterology; 2000; 47(35):1277-9. PubMed ID: 11100332
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
[TBL] [Abstract][Full Text] [Related]
3. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N
Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332
[TBL] [Abstract][Full Text] [Related]
4. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
[TBL] [Abstract][Full Text] [Related]
6. Immunologic detection of fecal occult blood from upper digestive tract diseases.
Nakama H; Kamijo N; Fattah AS; Zhang B
Hepatogastroenterology; 1998; 45(21):752-4. PubMed ID: 9684127
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the fecal occult blood test and benign anal disorders.
Sasaki K; Kunimoto M; Hirata K
Hepatogastroenterology; 2001; 48(38):445-7. PubMed ID: 11379329
[TBL] [Abstract][Full Text] [Related]
8. Lower specificity of occult-blood test on stool collected by digital rectal examination.
Zhang B; Nakama H; Fattah AS; Kamijo N
Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
Nakama H; Zhang B; Kamijo N
Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
[TBL] [Abstract][Full Text] [Related]
11. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging.
Boley SJ; Sammartano R; Adams A; DiBiase A; Kleinhaus S; Sprayregen S
Gastroenterology; 1977 Apr; 72(4 Pt 1):650-60. PubMed ID: 300063
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.
Abdul Fattah AS; Nakama H; Kamijo N
Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491
[TBL] [Abstract][Full Text] [Related]
13. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.
Kahi CJ; Imperiale TF
Am J Med; 2004 Dec; 117(11):837-41. PubMed ID: 15589487
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of several immunochemical tests for colorectal cancer.
Nakama H; Kamijo N; Miyata K; Abdul Fattah AS; Zhang B; Uehara Y
Hepatogastroenterology; 1998; 45(23):1579-82. PubMed ID: 9840108
[TBL] [Abstract][Full Text] [Related]
15. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
17. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
[TBL] [Abstract][Full Text] [Related]
18. Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test.
Herzog P; Holtermüller KH; Preiss J; Fischer J; Ewe K; Schreiber HJ; Berres M
Gastroenterology; 1982 Nov; 83(5):957-62. PubMed ID: 7117808
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
